Search

Bharati R Dhruva

Examiner (ID: 3913)

Most Active Art Unit
1632
Art Unit(s)
1632
Total Applications
2
Issued Applications
1
Pending Applications
1
Abandoned Applications
0

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6791560 [patent_doc_number] => 20030086904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Therapeutic regimen for treating cancer' [patent_app_type] => new [patent_app_number] => 10/151633 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 18359 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20030086904.pdf [firstpage_image] =>[orig_patent_app_number] => 10151633 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/151633
Therapeutic regimen for treating cancer comprising the administration of adenoviral vectors comprising a TNF-α transgene May 16, 2002 Issued
Array ( [id] => 6261783 [patent_doc_number] => 20020187936 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Methods of treating liver disease and liver damage with growth hormone and foxM1B' [patent_app_type] => new [patent_app_number] => 10/151587 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 23775 [patent_no_of_claims] => 144 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187936.pdf [firstpage_image] =>[orig_patent_app_number] => 10151587 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/151587
Methods of treating liver disease and liver damage with growth hormone and foxM1B May 16, 2002 Abandoned
Array ( [id] => 7275030 [patent_doc_number] => 20040234481 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Gene transfers of angiogenic factor for skin disease' [patent_app_type] => new [patent_app_number] => 10/477166 [patent_app_country] => US [patent_app_date] => 2004-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 9562 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20040234481.pdf [firstpage_image] =>[orig_patent_app_number] => 10477166 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/477166
Method of treating skin wounds with vectors encoding hepatocyte growth factor May 8, 2002 Issued
Array ( [id] => 6843082 [patent_doc_number] => 20030148429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/141705 [patent_app_country] => US [patent_app_date] => 2002-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63479 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148429.pdf [firstpage_image] =>[orig_patent_app_number] => 10141705 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/141705
Pro4399 Polypeptides May 7, 2002 Issued
Array ( [id] => 6773801 [patent_doc_number] => 20030017139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Regulatory elements for delivery to the liver' [patent_app_type] => new [patent_app_number] => 10/139763 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4086 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017139.pdf [firstpage_image] =>[orig_patent_app_number] => 10139763 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/139763
Regulatory elements for delivery to the liver May 5, 2002 Issued
Array ( [id] => 6692204 [patent_doc_number] => 20030039636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Novel self-inactivating (SIN) lentiviral vectors' [patent_app_type] => new [patent_app_number] => 10/137788 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10965 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20030039636.pdf [firstpage_image] =>[orig_patent_app_number] => 10137788 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/137788
Novel self-inactivating (SIN) lentiviral vectors Apr 30, 2002 Abandoned
Array ( [id] => 7199604 [patent_doc_number] => 20040205834 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-14 [patent_title] => 'System for inducible expression in eukaryotic cells' [patent_app_type] => new [patent_app_number] => 10/135362 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 11609 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0205/20040205834.pdf [firstpage_image] =>[orig_patent_app_number] => 10135362 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/135362
Cumate-inducible expression system for eukaryotic cells Apr 30, 2002 Issued
Array ( [id] => 6657119 [patent_doc_number] => 20030077829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-24 [patent_title] => 'Lipid-based formulations' [patent_app_type] => new [patent_app_number] => 10/136707 [patent_app_country] => US [patent_app_date] => 2002-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 11052 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20030077829.pdf [firstpage_image] =>[orig_patent_app_number] => 10136707 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/136707
Lipid-based formulations Apr 29, 2002 Abandoned
Array ( [id] => 7540405 [patent_doc_number] => 08058248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-15 [patent_title] => 'Foot and mouth disease virus vaccine comprising interferons' [patent_app_type] => utility [patent_app_number] => 10/128463 [patent_app_country] => US [patent_app_date] => 2002-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 11567 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/058/08058248.pdf [firstpage_image] =>[orig_patent_app_number] => 10128463 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/128463
Foot and mouth disease virus vaccine comprising interferons Apr 23, 2002 Issued
10/018729 Regulation system of expression using nuclear ppar receptors Apr 21, 2002 Abandoned
10/111052 Nucleic acid transporter containing polypeptides and recombinat virus vector Apr 18, 2002 Abandoned
Array ( [id] => 6869466 [patent_doc_number] => 20030082155 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Stem cells of the islets of langerhans and their use in treating diabetes mellitus' [patent_app_type] => new [patent_app_number] => 10/120687 [patent_app_country] => US [patent_app_date] => 2002-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 25498 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082155.pdf [firstpage_image] =>[orig_patent_app_number] => 10120687 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/120687
Stem cells of the islets of langerhans and their use in treating diabetes mellitus Apr 10, 2002 Abandoned
Array ( [id] => 4916 [patent_doc_number] => 07812148 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-12 [patent_title] => 'Vectors comprising CpG islands without position effect varigation and having increased expression' [patent_app_type] => utility [patent_app_number] => 10/117960 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 31 [patent_no_of_words] => 11375 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/812/07812148.pdf [firstpage_image] =>[orig_patent_app_number] => 10117960 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/117960
Vectors comprising CpG islands without position effect varigation and having increased expression Apr 4, 2002 Issued
Array ( [id] => 6869996 [patent_doc_number] => 20030082685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Chemotherapeutic induction of egr-1 promoter activity' [patent_app_type] => new [patent_app_number] => 10/117442 [patent_app_country] => US [patent_app_date] => 2002-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 27099 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082685.pdf [firstpage_image] =>[orig_patent_app_number] => 10117442 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/117442
Chemotherapeutic induction of egr-1 promoter activity Apr 4, 2002 Abandoned
Array ( [id] => 6682771 [patent_doc_number] => 20030118635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Polynucleotide binding complexes comprising sterols and saponins' [patent_app_type] => new [patent_app_number] => 10/114957 [patent_app_country] => US [patent_app_date] => 2002-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 43894 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20030118635.pdf [firstpage_image] =>[orig_patent_app_number] => 10114957 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/114957
Cage-like microparticle complexes comprising sterols and saponins for delivery of polynucleotides Apr 3, 2002 Issued
Array ( [id] => 6864782 [patent_doc_number] => 20030190308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-09 [patent_title] => 'Adjuvant' [patent_app_type] => new [patent_app_number] => 10/102622 [patent_app_country] => US [patent_app_date] => 2002-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 27329 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20030190308.pdf [firstpage_image] =>[orig_patent_app_number] => 10102622 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/102622
Adjuvant Mar 18, 2002 Abandoned
Array ( [id] => 6413871 [patent_doc_number] => 20020183333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-05 [patent_title] => 'Compositions and methods for chemotherapy having reduced nephrotoxicity' [patent_app_type] => new [patent_app_number] => 10/103520 [patent_app_country] => US [patent_app_date] => 2002-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7271 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20020183333.pdf [firstpage_image] =>[orig_patent_app_number] => 10103520 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/103520
Compositions and methods for chemotherapy having reduced nephrotoxicity Mar 18, 2002 Abandoned
Array ( [id] => 6047962 [patent_doc_number] => 20020168739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Vectors, compositions and methods for treating a vascular disorder' [patent_app_type] => new [patent_app_number] => 10/094210 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7285 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168739.pdf [firstpage_image] =>[orig_patent_app_number] => 10094210 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/094210
Vectors, compositions and methods for treating a vascular disorder Mar 7, 2002 Abandoned
Array ( [id] => 6843074 [patent_doc_number] => 20030148421 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Gene products that regulate glucose response in cells' [patent_app_type] => new [patent_app_number] => 10/080381 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 47773 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148421.pdf [firstpage_image] =>[orig_patent_app_number] => 10080381 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/080381
Gene products that regulate glucose response in cells Feb 18, 2002 Abandoned
10/060069 Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby Jan 28, 2002 Abandoned
Menu